Gabapentin - Menopausal disorders
You are here : Home > Formulary Search > Gabapentin - Menopausal disorders
Status 1
- Capsules
Documentation
PAD Profile
Off-label use.
Committee Recommendations (2)
The APC approved a change in Traffic Light Status from Blue to Green while reviewing drugs for inclusion on the Surrey Heartlands Joint Formulary.
It was agreed that GPs would initiate non-hormonal treatments for menopausal symptoms in accordance with CKS guidelines and NICE NG23: Menopause: identification and management
The Surrey & North West Sussex Area Prescribing Committee updated their recommendations in line with NICE guidance NG23 Menopause diagnosis and management in May 2020.
Gabapentinoids are recommended for menopausal symptoms and a BLUE (with no information sheet) traffic light status has been agreed. Please refer to the Menopause -NG23 briefing paper attached below for further information (Page 13/14). Gabapentenoids should not be routinely offered as a first line treatment for vasomotor symptoms.
Other Indications
Below are listed other indications that Gabapentin is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Menopausal disorders.
- Clonidine hydrochloride
- Conjugated oestrogens
- Conjugated oestrogens with medroxyprogesterone
- Drospirenone
- Duavive
- Dydrogesterone
- Estradiol
- Estradiol with dydrogesterone
- Estradiol with levonorgestrel
- Estradiol with medroxyprogesterone
- Estradiol with norethisterone
- Estradiol with progesterone
- Ethinylestradiol
- Fezolinetant
- Levonorgestrel
- Medroxyprogesterone acetate
- Non-Hormonal lubricants
- Paroxetine
- Pregabalin
- Progesterone
- St Johns Wort
- Tibolone
- Venlafaxine